ABSTRACT
Philip Morris International announced a dramatic New Year resolution for 2018: “We're trying to give up cigarettes.” This announcement represents a dramatic strategic shift for the company, a departure from the historical business of cigarettes to explore new revenue opportunities within the tobacco industry. Only time will tell if the biopharmaceutical industry makes a similar resolution to move away from traditional biopharmaceutical products and the associated business model.
